Nicole Cotroneo

715 total citations
27 papers, 544 citations indexed

About

Nicole Cotroneo is a scholar working on Molecular Medicine, Pharmacology and Epidemiology. According to data from OpenAlex, Nicole Cotroneo has authored 27 papers receiving a total of 544 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Medicine, 15 papers in Pharmacology and 15 papers in Epidemiology. Recurrent topics in Nicole Cotroneo's work include Antibiotic Resistance in Bacteria (18 papers), Antibiotics Pharmacokinetics and Efficacy (14 papers) and Urinary Tract Infections Management (8 papers). Nicole Cotroneo is often cited by papers focused on Antibiotic Resistance in Bacteria (18 papers), Antibiotics Pharmacokinetics and Efficacy (14 papers) and Urinary Tract Infections Management (8 papers). Nicole Cotroneo collaborates with scholars based in United States, Canada and Hong Kong. Nicole Cotroneo's co-authors include Ian A. Critchley, Rodrigo E. Mendes, Michael J. Pucci, Aileen Rubio, Robert J. Harris, Nancy G. Perlmutter, Jared Silverman, Terry J. Beveridge, Troy Lister and Akash Jain and has published in prestigious journals such as PLoS ONE, Antimicrobial Agents and Chemotherapy and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Nicole Cotroneo

26 papers receiving 516 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nicole Cotroneo United States	11	290	221	177	156	129	27	544
Barbara Körber-Irrgang Germany	12	269 0.9×	143 0.6×	124 0.7×	68 0.4×	59 0.5×	22	394
Siqiang Niu China	16	417 1.4×	170 0.8×	155 0.9×	154 1.0×	107 0.8×	41	665
Ashlan J. Kunz Coyne United States	13	214 0.7×	65 0.3×	85 0.5×	146 0.9×	56 0.4×	33	495
Keren Shi China	13	368 1.3×	128 0.6×	92 0.5×	138 0.9×	135 1.0×	19	491
Xiaohua Qin China	11	356 1.2×	124 0.6×	119 0.7×	90 0.6×	49 0.4×	20	478
Naglaa Mohamed United States	12	137 0.5×	80 0.4×	64 0.4×	136 0.9×	154 1.2×	31	446
F. Chau France	14	209 0.7×	190 0.9×	111 0.6×	78 0.5×	54 0.4×	26	423
Claudia Zampaloni Switzerland	13	168 0.6×	113 0.5×	103 0.6×	155 1.0×	172 1.3×	22	463
Jay Bergeron United States	6	178 0.6×	220 1.0×	106 0.6×	94 0.6×	227 1.8×	9	509
Jilu Shen China	12	228 0.8×	105 0.5×	79 0.4×	195 1.3×	73 0.6×	45	492

Countries citing papers authored by Nicole Cotroneo

Since Specialization

Citations

This map shows the geographic impact of Nicole Cotroneo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicole Cotroneo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicole Cotroneo more than expected).

Fields of papers citing papers by Nicole Cotroneo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicole Cotroneo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicole Cotroneo. The network helps show where Nicole Cotroneo may publish in the future.

Co-authorship network of co-authors of Nicole Cotroneo

This figure shows the co-authorship network connecting the top 25 collaborators of Nicole Cotroneo. A scholar is included among the top collaborators of Nicole Cotroneo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicole Cotroneo. Nicole Cotroneo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cotroneo, Nicole, et al.. (2024). Efficacy of SPR720 in murine models of non-tuberculous mycobacterial pulmonary infection. Journal of Antimicrobial Chemotherapy. 79(4). 875–882. 9 indexed citations

VanScoy, Brian, et al.. (2023). Evaluation of Oral Tebipenem as a Step-Down Therapy following Intravenous Ertapenem against Extended-Spectrum β-Lactamase-Producing Escherichia coli in a Hollow-Fiber In Vitro Infection Model. Antimicrobial Agents and Chemotherapy. 67(3). e0090822–e0090822. 3 indexed citations

Mendes, Rodrigo E., S J Ryan Arends, Jennifer M Streit, et al.. (2023). Contemporary Evaluation of Tebipenem In Vitro Activity against Enterobacterales Clinical Isolates Causing Urinary Tract Infections in US Medical Centers (2019–2020). Microbiology Spectrum. 11(1). e0205722–e0205722. 8 indexed citations

Mendes, Rodrigo E., Hélio S. Sader, S J Ryan Arends, et al.. (2022). 1677. In vitro Activity of SPR206 and Comparator Compounds against Enterobacterales Isolates Responsible for Infections in United States Hospitals. Open Forum Infectious Diseases. 9(Supplement_2). 3 indexed citations

Mendes, Rodrigo E., Hélio S. Sader, S J Ryan Arends, et al.. (2022). 1676. Activity of SPR206 and Comparator Agents Against Pseudomonas aeruginosa and Acinetobacter baumannii Causing Infections in United States Hospitals. Open Forum Infectious Diseases. 9(Supplement_2). 4 indexed citations

Cotroneo, Nicole, S. Stokes, Michael J. Pucci, et al.. (2022). In Vitro Resistance against DNA Gyrase Inhibitor SPR719 in Mycobacterium avium and Mycobacterium abscessus. Microbiology Spectrum. 10(1). e0132121–e0132121. 18 indexed citations

Arends, S J Ryan, et al.. (2021). 1044. In vitro Activity of Tebipenem Against Relevant Clinical Isolates in the Presence of Pulmonary Surfactant. Open Forum Infectious Diseases. 8(Supplement_1). S614–S614. 1 indexed citations

Mendes, Rodrigo E., et al.. (2021). 1036. In Vitro Analysis of AmpC β-lactamase Induction by Tebipenem in Enterobacterales and Pseudomonas aeruginosa. Open Forum Infectious Diseases. 8(Supplement_1). S608–S609. 1 indexed citations

Critchley, Ian A., Nicole Cotroneo, Michael J. Pucci, Akash Jain, & Rodrigo E. Mendes. (2020). Resistance among urinary tract pathogens collected in Europe during 2018. Journal of Global Antimicrobial Resistance. 23. 439–444. 22 indexed citations

10.

Cotroneo, Nicole, et al.. (2020). 1274. Evaluating the Activity of SPR719, a Novel Aminobenzimidazole, against Nontuberculous Mycobacteria. Open Forum Infectious Diseases. 7(Supplement_1). S653–S654. 1 indexed citations

11.

Deshpande, Devyani, Nicole Cotroneo, David Melnick, et al.. (2020). 1659. Pharmacokinetics/pharmacodynamics of the Novel Gyrase Inhibitor SPR719/SPR720 and Clinical Dose Selection to Treat Pulmonary Mycobacterium avium-complex Disease. Open Forum Infectious Diseases. 7(Supplement_1). S817–S817. 5 indexed citations

12.

Verma, Deepshikha, et al.. (2020). 1637. SPR720, A Novel Benzamidazole Gyrase Inhibitor, Demonstrates Potent Efficacy Against Mycobacterium avium ATCC 700898 in a Chronic C3HeBFeJ Mouse Infection Model. Open Forum Infectious Diseases. 7(Supplement_1). S809–S809. 4 indexed citations

13.

Critchley, Ian A., Nicole Cotroneo, Michael J. Pucci, Akash Jain, & Rodrigo E. Mendes. (2020). 1695. Tebipenem: An Oral Carbapenem with activity against Multi-drug Resistant Urinary Tract Infection isolates of Escherichia coli collected from US Medical Centers during 2019. Open Forum Infectious Diseases. 7(Supplement_1). S831–S831. 5 indexed citations

14.

Mendes, Rodrigo E., Paul R. Rhomberg, Troy Lister, et al.. (2020). In Vitro Activity Analysis of a New Polymyxin, SPR741, Tested in Combination with Antimicrobial Agents against a Challenge Set of Enterobacteriaceae , Including Molecularly Characterized Strains. Antimicrobial Agents and Chemotherapy. 65(1). 8 indexed citations

15.

McEntee, Laura, Adam Johnson, Nicola Farrington, et al.. (2019). Pharmacodynamics of Tebipenem: New Options for Oral Treatment of Multidrug-Resistant Gram-Negative Infections. Antimicrobial Agents and Chemotherapy. 63(8). 39 indexed citations

16.

Critchley, Ian A., Nicole Cotroneo, Michael J. Pucci, & Rodrigo E. Mendes. (2019). The burden of antimicrobial resistance among urinary tract isolates of Escherichia coli in the United States in 2017. PLoS ONE. 14(12). e0220265–e0220265. 111 indexed citations

17.

Mendes, Rodrigo E., Paul R. Rhomberg, Troy Lister, et al.. (2019). Evaluation of Antimicrobial Effects of a New Polymyxin Molecule (SPR741) When Tested in Combination with a Series of β-Lactam Agents Against a Challenge Set of Gram-Negative Pathogens. Microbial Drug Resistance. 26(4). 319–328. 10 indexed citations

18.

French, Shawn, Maya A. Farha, Michael J. Ellis, et al.. (2019). Potentiation of Antibiotics against Gram-Negative Bacteria by Polymyxin B Analogue SPR741 from Unique Perturbation of the Outer Membrane. ACS Infectious Diseases. 6(6). 1405–1412. 80 indexed citations

19.

Lam, Hiu Yung, et al.. (2016). Structure-activity relationship of daptomycin analogues with substitution at (2S, 3R) 3-methyl glutamic acid position. Bioorganic & Medicinal Chemistry Letters. 27(3). 456–459. 20 indexed citations

20.

Cotroneo, Nicole, Robert J. Harris, Nancy G. Perlmutter, Terry J. Beveridge, & Jared Silverman. (2008). Daptomycin Exerts Bactericidal Activity without Lysis of Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. 52(6). 2223–2225. 110 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact